ESMO 2022: Pegylated il-2 + nivolumab in renal cancer

Nizar Tannir describes this randomised phase 3 study presented at ESMO. 

2356 232

Suggested Podcasts

Ideabrew Studios

infoier | 设计乘数

Lew Later

Nate Treese and Jeff Partyka

Love John

Saaralpodcast

Aniket Kuril

Garcia Jones